Point72 Middle East FZE »

Royalty Pharma shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 113k 28.09
2023-09-30 $1.1M 40k 27.14
2023-06-30 $1.2M 38k 30.74
2023-03-31 $938k 26k 36.03

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma